United States Biotechnology & Medical Research

Urovant Sciences Ltd (UROV)

Track

Stock chart
Ticker: UROV Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Sumitomo Chemical Co., Ltd.
3 purchases — total 1,350,510 USD
Buy 19 Feb 2020
Value US$2,191,331.41 | Price 29.81 | Shares 54,091
Buy 19 Feb 2020
Value US$282,566.26 | Price 328.86 | Shares 24,041
Buy 19 Feb 2020
Value US$168,378.84 | Price 13.08 | Shares 12,873
Sale 27 Dec 2019
Value US$1,397,280.00 | Price 33.82 | Shares 30,515
Planned sale 9 Dec 2019
Value US$1,533,600.00 | Price 12.78 | Shares 120,000
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 19 Jun 2019
Value US$40,495.22 | Price 8.17 | Shares 4,957
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Planned buy 18 Jun 2019
Value US$55,060.95 | Price 8.21 | Shares 6,706
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-02-21 2020-02-19 B Purchase
Sumitomo Chemical Co., Ltd.
54,091 -43.9%
29.81
US$2,191,331 		54,091 -43.9% 29.81 US$2,191,331
2020-02-21 2020-02-19 B Purchase
Sumitomo Chemical Co., Ltd.
24,041 -44.0%
328.86
US$282,566 		24,041 -44.0% 328.86 US$282,566
2020-02-21 2020-02-19 B Purchase
Sumitomo Chemical Co., Ltd.
52,087 -49.9%
89.96
US$4,634,471 		52,087 -49.9% 89.96 US$4,634,471
2019-12-31 2019-12-27 S Sale Roivant Sciences Ltd. Large shareholder
22,860,013
0.00
US$0 		22,860,013 0.00 US$0
2019-12-11 2019-12-09 PlS Planned sale Katkin Keith

PEO;CEO/Urovant Sciences, Inc.

Executive Director
120,000 -100.0%
12.78
US$1,533,600 		120,000 -100.0% 12.78 US$1,533,600
2019-06-19 2019-06-19 PP Planned purchase
QVT Associates GP LLC
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
1.5
Machado Patrick
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
2.5
Lo Andrew
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-19 PP Planned purchase
1.9
Roivant Sciences Ltd.
Large shareholder
4,957 +0.0%
8.17
US$40,495 		4,957 +0.0% 8.17 US$40,495
2019-06-19 2019-06-18 PP Planned purchase
QVT Associates GP LLC
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
1.5
Machado Patrick
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
2.5
Lo Andrew
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
Dexxon Holdings Ltd.
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
2019-06-19 2019-06-18 PP Planned purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
6,706 +0.0%
8.21
US$55,061 		6,706 +0.0% 8.21 US$55,061
Explore more

More insider trading research around Urovant Sciences Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America